← All trials
NCT04916886
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 3, 2021
- Primary completion
- May 31, 2022
- Completion date
- Aug 31, 2022
- First posted
- Jun 8, 2021
- Last posted
- Jun 8, 2021
- Enrollment
- 2016
- Arms / groups
- 9 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Tianjin Cansino Biotechnology IncLead sponsor
- Government of ChinaCollaborator
- Government of ChinaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.